Phio Pharmaceuticals Corp Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 147.25 K | $179.65 K | 58.96% | 1.27% |
| JANE STREET GROUP, LLC | 05/12/2026 | 119.19 K | $145.41 K | 100.00% | 1.03% |
| 05/15/2026 | 79.85 K | $97.42 K | 100.00% | 0.69% | |
| CETERA INVESTMENT ADVISERS | 05/13/2026 | 45.00 K | $54.90 K | 5.88% | 0.39% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 38.17 K | $46.57 K | 100.00% | 0.33% |
| HRT FINANCIAL LP | 05/14/2026 | 34.73 K | $42.00 K | 100.00% | 0.30% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 32.50 K | $39.64 K | 124.20% | 0.28% |
| SCIENTECH RESEARCH LLC | 05/15/2026 | 30.03 K | $36.64 K | 100.00% | 0.26% |
| UBS GROUP AG | 05/05/2026 | 26.99 K | $32.93 K | 214.02% | 0.23% |
| XTX TOPCO LTD | 05/15/2026 | 24.87 K | $30.34 K | 100.00% | 0.21% |
| NORTHERN TRUST CORP | 05/14/2026 | 23.76 K | $28.99 K | 0.00% | 0.20% |
| GSA CAPITAL PARTNERS LLP | 05/08/2026 | 19.86 K | $24.00 K | 100.00% | 0.17% |
| TWO SIGMA SECURITIES, LLC | 05/15/2026 | 15.22 K | $18.57 K | 100.00% | 0.13% |
| CAPTRUST FINANCIAL ADVISORS | 05/15/2026 | 10.00 K | $12.20 K | 0.00% | 0.09% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 7.62 K | $9.30 K | 100.00% | 0.07% |
| MORGAN STANLEY | 05/15/2026 | 6.00 K | $7.32 K | 0.00% | 0.05% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 2.00 K | $2.44 K | 100.00% | 0.02% |
| SPIRE WEALTH MANAGEMENT | 04/22/2026 | 2.00 K | $2.44 K | 100.00% | 0.02% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 1.22 K | $1.49 K | 7.84% | 0.01% |
| NBC SECURITIES, INC. | 04/14/2026 | 1.07 K | $1.31 K | 100.00% | 0.01% |
| CITIGROUP INC | 05/11/2026 | 1.03 K | $1.25 K | 100.00% | 0.01% |
| ASSETMARK, INC | 05/06/2026 | 110 | $134 | 0.00% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 04/15/2026 | 9 | $11 | 0.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 05/11/2026 | 3 | $4 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| STONEX GROUP INC. | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| DRW SECURITIES, LLC | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| ROBERTSON STEPHENS WEALTH MANAGEMENT, LLC | 04/28/2026 | 0 | $0 | -100.00% | 0.00% |
Phio Pharmaceuticals Corp institutional Ownership - FAQ's
During the previous two years, 30 institutional investors and hedge funds held shares of Phio Pharmaceuticals Corp. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 147,254
JANE STREET GROUP, LLC: 119,189
Cetera Investment Advisers: 45,000
VANGUARD FIDUCIARY TRUST CO: 38,169
HRT FINANCIAL LP: 34,732
TWO SIGMA INVESTMENTS, LP: 32,495
5.75% of Phio Pharmaceuticals Corp stock is owned by institutional investors.
Institutional investors have bought a total of 676.27 K shares in the last 24 months. This purchase volume represents approximately $818.28 K in transactions.